Back to Results
First PageMeta Content
Oncology / Tumor antigen / Prostate cancer / Vaccine / Cancer immunotherapy / Lloyd J. Old / Medicine / Vaccination / Cancer vaccine


Media Release For Immediate Release ImmunoVaccine Technologies Licenses Immunotope’s Breast, Ovarian and Prostate Cancer Antigens Halifax, Nova Scotia; July 14, 2009 – ImmunoVaccine Technologies Inc. (IVT), a vaccine
Add to Reading List

Document Date: 2011-03-06 09:05:21

Open Document

File Size: 70,19 KB

Share Result on Facebook

City

Halifax / /

Company

Immunotope Inc. / ImmunoVaccine Technologies Inc. / Pfizer Animal Health / /

/

Event

Business Partnership / FDA Phase / /

Facility

Yokohoma City University / /

IndustryTerm

injection site / applicable securities law / /

MedicalCondition

infection disease / cancer / therapeutic cancer / diseases / ovarian and prostate cancers / /

MedicalTreatment

immunotherapy / /

Organization

National Institute of Health / City University / /

Person

Randal Chase / Ramila Philip / /

/

Position

president / president & CEO / /

Product

DepoVax / DPX-0907 / /

ProvinceOrState

Nova Scotia / /

Technology

DepoVax™ technology / /

URL

www.immunovaccine.com / /

SocialTag